Famotidine thrombocytopenia

4 oct 2023 ... ... thrombocytopenia. The relationship between these events and famotidine therapy has been unclear in many cases.[44392]. Miscellaneous adverse ...

Famotidine is an acid-suppressing agent that may be used to treat a wide range of gastric-acid-related disorders including gastric ulcers, heartburn, and GERD. A headache is the most common side... more. Prescription only. Pantoprazole is a proton pump inhibitor that decreases acid secretion in the stomach and may be given to relieve the ...10 mar 2022 ... ... famotidine, magnesium hydroxide (NAP) - PSUSA/00001351/202009 89 ... Fostamatinib is a spleen tyrosine kinase inhibitor indicated, as Tavlesse, ...Use another famotidine formulation for pediatric patients weighing less than 40 kg. Table 1: Recommended Dosage and Duration of PEPCID Tablets in Adult and Pediatric Patients 40 kg and ... Hematologic: thrombocytopenia Hypersensitivity: orbital edema, rash, conjunctival injection, bronchospasmFamotidine: learn about side effects, dosage, special precautions, and more on MedlinePlus Prescription famotidine is used to treat ulcers (sores on the lining of the stomach or small intestine); gastroesophageal reflux disease (GERD, a con...Dosing for oral administered famotidine was 20 mg/d in 95.2% of cases and 40 mg/d in the remaining 4.8% of cases. Intravenous famotidine was administered as a 20 mg/2 mL solution in all cases, For inpatient famotidine use, the median total dose was 80 mg (range 40–160 mg) and was received over a median of 4 days (range 2–8 days). Famotidine is a competitive inhibitor of histamine H 2-receptors. The primary clinically important pharmacologic activity of Famotidine is inhibition of gastric secretion. ... Hematologic: rare cases of agranulocytosis, pancytopenia, leukopenia, thrombocytopenia. Hypersensitivity: anaphylaxis, angioedema, orbital or facial edema, urticaria ...Thrombocytopenia is a rare adverse effect of famotidine therapy. 4-7. Few cases of famotidine-induced thrombocytopenia have been reported. Case reports have suggested two potential mechanisms of H2 antagonist-induced thrombocytopenia. The first is bone marrow suppression secondary to inhibition of DNA synthesis. The second mechanism

Hematologic: thrombocytopenia . Hypersensitivity: orbital edema, rash, conjunctival injection, bronchospasm . ... Famotidine tablets may be taken with or without food. Famotidine tablets may be given with antacids. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.Immune thrombocytopenia (ITP) is a commonest blood disorder that causes thrombocytopenia or low platelet count. Apart from ITP, many drugs can cause thrombocytopenia. Some drugs like anticancer drugs and valproic acid causes dose depended decrease in the number of platelets by myelosuppression. Drugs may also cause thrombocytopenia by ...The use of PEPCID 20 mg and 40 mg tablets is not recommended for use in pediatric patients weighing less than 40 kg because the lowest available strength (20 mg) exceeds the recommended dose for these patients. Use another famotidine formulation for pediatric patients weighing less than 40 kg. Drug-Induced Immune Thrombocytopenia ... FAMOTIDINE - FELBAMATE + FELODIPINE + FENOFIBRATE - FENTANYL + DRUG DDAB FEXOFENADINE + FINASTERIDE -Thrombocytopenia is a rare adverse effect of famotidine therapy. 4-7. Few cases of famotidine-induced thrombocytopenia have been reported. Case reports have …Famotidine (Pepcid). Category: Gastrointestinal. Description: Antiulcer agent ... HEME: Thrombocytopenia. RESP: Bronchospasm. Arthralgia, myalgia, rash. Dosage ...H 2 antagonist ranitidine causing thrombocytopenia is a rare drug phenomenon. Here we present a case of 55 year old female of pustular psoriasis who presented with fever and …

Drug-induced immune thrombocytopenia (DITP) is an idiosyncratic drug reaction caused by drug-dependent platelet antibodies, 1 often causing thrombocytopenia and mucocutaneous bleeding. 1 Chemotherapy agents have been documented as triggers for DITP. 2 By contrast, few cases of trastuzumab-related thrombocytopenia have been reported to date, …2023 ASCO Annual Meeting. Springer Medicine. SearchJul 24, 2023 · Some dosage forms listed on this page may not apply to the brand name Pepcid. Applies to famotidine: oral powder for suspension, oral tablet. Serious side effects of Pepcid. Along with its needed effects, famotidine (the active ingredient contained in Pepcid) may cause some unwanted effects. Although not all of these side effects may occur, if ... While hematologi- cal side effects for famotidine, including neu- tropenia and thrombocytopenia, have been reported, albeit rarely [18-21], plasmacytosis.Patients receiving other drugs or with known bleeding in the upper part of the gastrointestinal tract, thrombocytopenia, or coagulopathy were excluded. Results: A total of 522 patients who received famotidine and 95 who received pantoprazole were included. Bleeding in the upper part of the gastrointestinal tract was more common in patients ... Famotidine is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. 12.1 Mechanism of Action. Famotidine is a competitive inhibitor of histamine-2 (H2) receptors.

Legal help for students.

Background Chemoradiotherapy complications has always been of great concern to both clinicians and patients during the course of treatment. The purpose of the present study was to examine the effectiveness of oral famotidine on the reduction of hematologic complications of patients with esophageal and gastric cardia cancers undergoing radiotherapy. Methods A single-blind controlled trial was ...In patients with severe thrombocytopenia, predicted 5-year mortality rates from bleeding are significantly raised in patients older than age 60 and those under age 40 -- 47.8% versus 2.2% ...Famotidine is metabolised in the liver, with formation of the inactive sulfoxide metabolite. Elimination. Famotidine is excreted mainly unchanged in the urine (25-60%); a small amount of the drug may be excreted as sulfoxide. Linearity/non-linearity. Famotidine displays linear kinetics. Thrombocytopenia is a medical condition characterized by low levels of platelets in the blood. It can happen because of reduced production of platelets in the bone marrow, destruction of platelets, or dilution of platelets in the bloodstream. Platelets, also known as thrombocytes, are small colorless blood cells that are responsible for the ...pantoprazole to famotidine due to possible PPI-induced thrombocytopenia. Consequently, pantoprazole therapy was discontinued, oral famotidine 10 mg once daily was initiated, and 2 units of platelets were 2022 Phan et al. Cureus 14(2): e22326. DOI 10.7759/cureus.22326 2 of 6

Hematologic: thrombocytopenia. Hypersensitivity: orbital edema, rash, conjunctival injection, bronchospasm. ... Famotidine tablets may be taken with or without food. Famotidine tablets may be given with antacids. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.Famotidine (Pepcid) is an oral drug used to treat symptoms of acid reflux and heartburn. Learn about side effects, warnings, dosage, and more.1 dic 1998 ... Purpose: To determine the strength of clinical evidence for individual drugs as a cause of thrombocytopenia.Report signs of agranulocytosis and neutropenia (fever, sore throat, mucosal lesions, signs of infection, bruising), aplastic anemia (unusual fatigue, weakness), or thrombocytopenia (bruising, bleeding gums, nose bleeds).Famotidine is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. Each tablet for oral administration contains either 20 mg or 40 mg of famotidine and the followingPathologic elevation of conjugated or direct bilirubin (concentration higher than 2 mg/dL or more than 20% of total bilirubin) is termed conjugated hyperbilirubinemia.[1] It is a biochemical marker of cholestasis and hepatocellular dysfunction.[1] Approximately 80% of the bilirubin is derived from hemoglobin metabolism.[2] The breakdown of heme molecules in …Famotidine is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. 12.1 Mechanism of Action. Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. abnormalities, vitamin deficiencies, drug interactions, thrombocytopenia, etc) through ... **Famotidine oral solution should be used in patients with feeding ...Sep 23, 2010 · To address this common clinical problem, we used 3 distinct analytical methods and their corresponding datasets to identify drugs that have evidence for an association with thrombocytopenia: (1) We performed serial systematic reviews of published case reports of DITP and analyzed the clinical evidence for a causal association of the drug with thrombocytopenia. 9,10 (2) We analyzed data from ... A dichotomous dose effect of acid suppressants was analyzed according to the mean daily dose while receiving mechanical ventilation, with high daily dose defined for H 2 RAs as greater than 40 mg for famotidine, greater than 150 mg for ranitidine hydrochloride if intravenous or greater than 300 mg if enteral, greater than 300 mg for nizatidine ...

thrombocytopenia; renal failure with estimated creatinine clearance less than 10 ml / min; active cancer; known allergic to aspirin, famotidine or pantoprazole ...

Case 1, a 6-year-old, spayed female Pug, presented with severe systemic urticaria, edema, and erythema. The dog had received a famotidine injection as a treatment for repeated vomiting in another hospital. On physical examination, hyperthermia was observed. Moderate pancytopenia, hypoalbuminemia, and increased CRP and D-dimer …Probable famotidine-induced thrombocytopenia DICP. 1991 Jun;25(6):678. doi: 10.1177/106002809102500622. Authors A E Zimmermann, B G Katona, V R ...pantoprazole to famotidine due to possible PPI-induced thrombocytopenia. Consequently, pantoprazole therapy was discontinued, oral famotidine 10 mg once daily was initiated, and 2 units of platelets were 2022 Phan et al. Cureus 14(2): e22326. DOI 10.7759/cureus.22326 2 of 6Introduction. Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease in the platelet count and increased risk of bleeding [].ITP in adults is a clinically distinct condition from that in children, with a lower likelihood of spontaneous remission, a higher incidence of underlying diseases and comorbidities, and …Thrombocytopenia (throm-buh-sye-tuh-PEE-nee-uh) is when there aren't as many normal platelets in the blood as there should be. Platelets are tiny colorless cells in the blood that help the blood clot. Like all blood cells, platelets are made in the bone marrow (the spongy inner part of bones).Abstract. H 2 antagonist ranitidine causing thrombocytopenia is a rare drug phenomenon. Here we present a case of 55 year old female of pustular psoriasis who presented with fever and vomiting. Patient. was started on roxithromycin, iv ondensetron, paracetamol and iv ranitidine. Complete blood count revealed neutrophilia with normal blood picture.Adverse effects of histamine (H 2 )-receptor antagonists (H 2 RAs) are uncommon and include diarrhoea, headache, dizziness, rash, and tiredness. Rare or very rare adverse effects include hepatitis, cholestatic jaundice, bradycardia, depression, confusion, hallucinations, leucopenia, thrombocytopenia, and pancytopenia, arthralgia, and myalgia.abnormalities, vitamin deficiencies, drug interactions, thrombocytopenia, etc) through ... **Famotidine oral solution should be used in patients with feeding ...

Womens big 12.

Spencer riley.

Thrombocytopenia is a medical condition characterized by low levels of platelets in the blood. It can happen because of reduced production of platelets in the bone marrow, destruction of platelets, or dilution of platelets in the bloodstream. Platelets, also known as thrombocytes, are small colorless blood cells that are responsible for the ...Thrombocytopenia means there are low levels of circulating platelets. A platelet count below 150,000/ µL is considered low. As such, a platelet count of 20,000/µL is consistent with a diagnosis of thrombocytopenia. A normal hemoglobin level is 12-17 g/dL depending on the sex of the patient.Some side effects of famotidine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. ... Rare (0.01% to 0.1%): Thrombocytopenia, leukopenia ...Seventy-two of 181 (39.8%) patients treated with famotidine developed thrombocytopenia compared with 23 of 126 (18.3%) untreated patients (P < 0.001). Patients who developed thrombocytopenia were ...Some side effects of famotidine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. ... Rare (0.01% to 0.1%): Thrombocytopenia, leukopenia ...Thrombocytopenia is a rare adverse effect of famotidine therapy. 4-7. Few cases of famotidine-induced thrombocytopenia have been reported. Case reports have suggested two potential mechanisms of H2 antagonist-induced thrombocytopenia. The first is bone marrow suppression secondary to inhibition of DNA synthesis. The second mechanismThrombocytopenia is a frequent complication that usually occurs in the first week after orthotopic liver transplantation (OLT *) .Although several factors, such as sequestration of the platelets in the reperfused liver graft, immunologic reactions, increased platelet consumption, reduced platelet production, impaired production of thrombopoietin, medication, platelet transfusions, heparin ...Mar 15, 2018 · Abstract. Splenectomy is an effective therapy for steroid-refractory or dependent immune thrombocytopenia (ITP). With the advent of medical alternatives such as rituximab and thrombopoietin receptor antagonists, the use of splenectomy has declined and is generally reserved for patients that fail multiple medical therapies. Thrombocytopenia, if left untreated, increases the risk of rebleeding and hemodynamic instability, which may be devastating to patients suffering from UGIBs. ... recommended transfusing platelets to maintain a goal platelet count of >20,000 cells/uL and to switch pantoprazole to famotidine due to possible PPI-induced thrombocytopenia ...Drug-induced thrombocytopenia (DITP), which also includes thrombocytopenia induced by beverages, foods, and herbal remedies, is an important clinical problem for hematologists. DITP typically appears suddenly, is often severe, and can cause major bleeding and death. 1 – 3 In many patients, the drug etiology is not initially recognized. ….

Agreed. Typically the ICU team is reaching for the stars on why a patients platelet count is low and blame it on the Pepcid. Lots of reasons an ICU patient can be thrombocytopenic. Platelets are a bit of an acute phase reactant, infection, inflammation, fever, DIC, stress, HIT, malnutrition, thrombocytopenia of frequent phlebotomy, hemorrhage ...Drug-Induced Immune Thrombocytopenia ... FAMOTIDINE - FELBAMATE + FELODIPINE + FENOFIBRATE - FENTANYL + DRUG DDAB FEXOFENADINE + FINASTERIDE -Shalev, O, Seror, D. Cimetidine and ranitidine may not cross-react to cause thrombocytopenia. J Intern Med 1991 ; 230: 87 – 8 . Google Scholar | Crossref | Medline | ISIDrug-induced immune thrombocytopenia (DITP) is an idiosyncratic drug reaction caused by drug-dependent platelet antibodies, 1 often causing thrombocytopenia and mucocutaneous bleeding. 1 Chemotherapy agents have been documented as triggers for DITP. 2 By contrast, few cases of trastuzumab-related thrombocytopenia have been reported to date, …Thrombocytopenia is a potential adverse effect of PPIs and H2RA. Thrombocytopenia can be risk factor for morbidity and mortality in ICU patients but can have numerous causes in the ICU. The goal of our study is to explore the relationship between incidence of acquired thrombocytopenia amongst mechanically ventilated patients receiving PPIs vs ...famotidine will decrease the level or effect of atazanavir by increasing gastric pH. Applies only to oral form of both agents. ... Hematologic: Rare cases of agranulocytosis, pancytopenia, leukopenia, thrombocytopenia. Hypersensitivity: Anaphylaxis, angioedema, orbital or facial edema, urticaria, rash, conjunctival injection.Pepcid has an average rating of 6.0 out of 10 from a total of 10 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 30% reported a negative effect. Protonix has an average rating of 7.2 out of 10 from a total of 81 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 23% reported a negative effect.It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers.This form of famotidine is given by vein and is used to treat these conditions for a short time when you cannot take the medication by mouth. Famotidine thrombocytopenia, The phase IV clinical study analyzes which people take Pepcid and have Thrombocytopenia. It is created by eHealthMe based on reports of 48,403 people who have side effects when taking Pepcid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions. Phase IV trials are used to detect adverse ..., Probable Famotidine-Induced Thrombocytopenia Authors Ahmad Rahal University of Kansas Medical Center:KU School of Medicine-Wichita, 1010 North Kansas, Wichita, KS 67214-3199, USA., Dec 10, 2017 · Proton pump inhibitors (PPIs) are the most effective and preferred class of drugs used to treat peptic ulcer disease, gastroesophageal reflux disease, and other diseases associated with increased production of gastric acid. PPIs in general have an excellent long-term safety profile and are well-tolerated. However, studies have shown some adverse reactions (e.g., osteoporosis,<i> Clostridium ... , First, famotidine could potentially inhibit the 3-chymotrypsin-like protease (3CLpro), which processes proteins essential for viral replication [9, 10, 15]. Famotidine may also activate G-protein-coupled receptors (GPCRs) which was presumed to active immune cell mobilization, and result in vascular inflammation [11, 38]., When medicines or drugs cause a low platelet count, it is called drug-induced thrombocytopenia. Causes Drug-induced thrombocytopenia occurs when certain medicines destroy platelets or interfere with the body's ability to make enough of them. There are two types of drug-induced thrombocytopenia: immune and nonimmune., Agreed. Typically the ICU team is reaching for the stars on why a patients platelet count is low and blame it on the Pepcid. Lots of reasons an ICU patient can be thrombocytopenic. Platelets are a bit of an acute phase reactant, infection, inflammation, fever, DIC, stress, HIT, malnutrition, thrombocytopenia of frequent phlebotomy, hemorrhage ..., Thrombocytopenia (throm-buh-sye-tuh-PEE-nee-uh) is when there aren't as many normal platelets in the blood as there should be. Platelets are tiny colorless cells in the blood that help the blood clot. Like all blood cells, platelets are made in the bone marrow (the spongy inner part of bones). , Famotidine is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. Each tablet for oral administration contains either 20 mg or 40 mg of famotidine and the following, Generic Name Mirtazapine DrugBank Accession Number DB00370 Background. Mirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994. 13 This drug was first manufactured by Organon Inc., and received FDA approval in 1997 for the treatment of …, Apr 7, 2018 · Transient thrombocytopenia is a common phenomenon after liver transplantation. After liver transplantation (LT), platelet count decreases and reaches a nadir on postoperative days 3-5, with an average reduction in platelet counts of 60%; platelet count recovers to preoperative levels approximately t … , Availability: 10 mg, 20 mg, 40 mg tablets; 40 mg/5 mL suspension; 10 mg/mL, 20 mg/50 mL injection. Contraindications: Safe use during pregnancy (category B), by nursing mothers. Cautious Use: Renal insufficiency. Route & Dosage: Duodenal Ulcer, Adult: PO 40 mg h.s. or 20 mg b.i.d. PO Maintenance Therapy 20 mg h.s. IV 20 mg q12h. Pathological ..., Thrombocytopenia is a potential adverse effect of PPIs and H2RA. Thrombocytopenia can be risk factor for morbidity and mortality in ICU patients but can have numerous causes in the ICU. The goal of our study is to explore the relationship between incidence of acquired thrombocytopenia amongst mechanically ventilated patients receiving PPIs vs ..., Seventeen of 50 (34%) patients on famotidine developed thrombocytopenia compared with 11 of 98 (11.2%) of those untreated (P = 0.002). In this retrospective study, …, Thrombocytopenia treatment can involve ongoing monitoring, blood transfusions, medications, and, in some cases, surgery. Learn about these options., Thrombocytopenia is a medical condition characterized by a low platelet count in the blood. Normally, platelets are responsible for blood clotting, and a low platelet count can lead to bleeding, bruising, and other complications. Thrombocytopenia is said when platelet count falls below 150,000. Thrombocytopenia can be caused by diseases that ..., Aster RH, Bougie DW. Current Concepts: Drug-induced Thrombocytopenia. New Engl J Med 2007 357: 580-587. Kuter DJ.Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med. 2009;60:193-206. , 2.1 Recommended Dosage. Table 1 shows the recommended dosage of Famotidine 20 mg and 40 mg tablets in adults and pediatric patients weighing 40 kg or greater with normal renal function. The use of Famotidine 20 mg and 40 mg tablets is not recommended for use in pediatric patients weighing less than 40 kg because the lowest available strength (20 mg) exceeds the …, UpToDate, electronic clinical resource tool for physicians and patients that provides information on Adult Primary Care and Internal Medicine, Allergy and Immunology, Cardiovascular Medicine, Emergency Medicine, Endocrinology and Diabetes, Family Medicine, Gastroenterology and Hepatology, Hematology, Infectious Diseases, Nephrology and Hypertension, Neurology, …, Sep 16, 2021 · Proton pump inhibitors (PPIs), followed by histamine 2 receptor antagonists (H2RAs), are the most commonly used drugs to prevent gastrointestinal bleeding in critically ill patients through stress ... , Treatment of patients suspected of having drug-induced immune thrombocytopenia. Immediate discontinuation of the drug responsible is the initial step for the treatment of DITP. In patients receiving multiple medications, if feasible, all compounds started within the last 5-10 days should be stopped and replaced., Probable Famotidine-Induced Thrombocytopenia Show all authors. Anthony E. Zimmermann, B.S.Pharm. Anthony E. Zimmermann. Senior Clinical Pharmacist Department of Pharmacy Harbor Hospital Center 3001 South Hanover Street Baltimore, Maryland 21230 See all articles by this author., Kansas Journal of Medicine 2015 Famotidine-Induced Thrombocytopenia 29 Drug Intell Clin Pharm 1989; 23(6):507-508. PMID: 2568035 5 Zimmermann AE, Katona BG, Hrehorovich VR. Probable famotidine-induced thrombocytopenia. 1991; DICP 25(6):678. PMID: 1877281. 6 Humphries JE. Thrombocytopenia associated with famotidine in a, Thrombocytopenia means there are low levels of circulating platelets. A platelet count below 150,000/ µL is considered low. As such, a platelet count of 20,000/µL is consistent with a diagnosis of thrombocytopenia. A normal hemoglobin level is 12-17 g/dL depending on the sex of the patient., The purpose of this study was to assess the incidence and clinical significance of famotidine-associated thrombocytopenia in the trauma patient population. A retrospective cohort study was performe..., Last Updated: 30 Aug 2023. PDF | On Feb 27, 2015, Ahmad K. Rahal and others published Probable Famotidine-Induced Thrombocytopenia | Find, read and …, Jun 6, 2022 · Diagnosis of drug-induced immune thrombocytopenia. Five clinical criteria have been proposed to help physicians to determine the diagnosis of DITP 1: 1) exposure to new drugs 5-10 days before onset of thrombocytopenia; 2) recovery from thrombocytopenia after discontinuing the candidate drug; 3) other drugs were continued or reintroduced after discontinuation of the candidate drug with a ... , Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelet count, purpura, and hemorrhagic episodes caused by antiplatelet autoantibodies. The diagnosis is typically made by excluding the known causes of thrombocytopenia. IgG autoantibodies sensitize the circulating platelets. It leads to …, 10 mar 2022 ... ... famotidine, magnesium hydroxide (NAP) - PSUSA/00001351/202009 89 ... Fostamatinib is a spleen tyrosine kinase inhibitor indicated, as Tavlesse, ..., Worsening cytopenias, defined as development of new-onset anemia, thrombocytopenia, or leukopenia; or hemoglobin drop greater than 2 g/dl, or transfusion requirements. Bone marrow disorder, defined as morphologic, flow cytometric, and/or cytogenetic evidence of a primary bone marrow disorder. Stable disease, if none of the …, 10 mar 2022 ... ... famotidine, magnesium hydroxide (NAP) - PSUSA/00001351/202009 89 ... Fostamatinib is a spleen tyrosine kinase inhibitor indicated, as Tavlesse, ..., 1 dic 1998 ... Purpose: To determine the strength of clinical evidence for individual drugs as a cause of thrombocytopenia., Drug-Induced Immune Thrombocytopenia ... FAMOTIDINE - FELBAMATE + FELODIPINE + FENOFIBRATE - FENTANYL + DRUG DDAB FEXOFENADINE + FINASTERIDE -, The phase IV clinical study analyzes which people take Pepcid and have Thrombocytopenia. It is created by eHealthMe based on reports of 48,403 people who have side effects when taking Pepcid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions. Phase IV trials are used to …